IART Q2 2025 Earnings — Integra LifeSciences Holdings Corporation Revenue & Financial Results | Market Cap Arena

IARTIntegra LifeSciences Holdings Corporation

$738M

Q2 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$416M-0.6% YoY

Gross Profit

$209M50.4% margin

Operating Income

-$513M-123.4% margin

Net Income

-$484M-116.5% margin

EPS (Diluted)

$-6.33

QoQ Revenue Growth

+8.6%

Cash Flow

Operating Cash Flow

$9M

Free Cash Flow

-$11M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$3.7B

Total Liabilities

$2.6B

Stockholders' Equity

$1.0B

Cash & Equivalents

$218M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$416M	$418M	-0.6%
Gross Profit	$209M	$226M	-7.3%
Operating Income	-$513M	-$3M	-16825.5%
Net Income	-$484M	-$12M	-3803.2%

Revenue Segments

Codman Specialty Surgical

$304M73%

Tissue Technologies

$112M27%

Geographic Segments

UNITED STATES

$306M74%

Asia Pacific

$48M11%

Europe

$43M10%

Rest Of The World

$19M5%